|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/6883 | |
| C12Q 1/6809 | |||
| C12Q 1/6897 | |||
| G01N 33/68 |
| (11) | Patento numeris | 3192880 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16191567.3 |
| Europos patento paraiškos padavimo data | 2011-08-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-07-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 374967 P | 2010-08-18 | US | |
| 384609 P | 2010-09-20 | US | |
| 201161513456 P | 2011-07-29 | US | |
| 201161513467 P | 2011-07-29 | US |
| (72) |
SNIDER, Lauren, US
VAN DER MAAREL, Silvčre, M., NL
TAPSCOTT, Stephen, J., US
TAWIL, Rabi, US
LEMMERS, Richard, J.L.F., NL
GENG, Linda, US
|
| (73) |
Leiden University Medical Center,
Albinusdreef 2, 2333 ZA Leiden,
NL
Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, US University of Rochester, 601 Elmwood Avenue Box OTT, Rochester, NY 14642, US |
| (54) | NUCLEIC ACID AGENTS FOR USE IN TREATING FACIOSCAPULOHUMERAL DYSTROPHY (FSHD) |
| NUCLEIC ACID AGENTS FOR USE IN TREATING FACIOSCAPULOHUMERAL DYSTROPHY (FSHD) |